These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8227758)

  • 41. Lithium response and genetics of affective disorders.
    Grof P; Alda M; Grof E; Zvolsky P; Walsh M
    J Affect Disord; 1994 Oct; 32(2):85-95. PubMed ID: 7829768
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Carbamazepine vs lithium in the treatment and prophylaxis of mania.
    Lusznat RM; Murphy DP; Nunn CM
    Br J Psychiatry; 1988 Aug; 153():198-204. PubMed ID: 3151275
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The comparative prophylactic efficacy of lithium and carbamazepine in patients with bipolar I disorder.
    Greil W; Kleindienst N
    Int Clin Psychopharmacol; 1999 Sep; 14(5):277-81. PubMed ID: 10529070
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
    Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
    J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The efficacy of low-dose lithium: clinical, psychological and biological correlates.
    Abou-Saleh MT; Coppen A
    J Psychiatr Res; 1989; 23(2):157-62. PubMed ID: 2511299
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Psychopathology during long-term lithium treatment of patients with major affective disorders. A prospective study.
    Nilsson A; Axelsson R
    Acta Psychiatr Scand; 1989 Oct; 80(4):375-88. PubMed ID: 2511737
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Overcoming resistance to lithium prophylaxis].
    Soucek K
    Cesk Psychiatr; 1991 Apr; 87(2):73-5. PubMed ID: 1913949
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prophylactic efficacy of carbamazepine in manic-depressive illness.
    Post RM; Uhde TW; Ballenger JC; Squillace KM
    Am J Psychiatry; 1983 Dec; 140(12):1602-4. PubMed ID: 6139957
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-adherence with long-term prophylaxis: a 6-year naturalistic follow-up study of affectively ill patients.
    Schumann C; Lenz G; Berghöfer A; Müller-Oerlinghausen B
    Psychiatry Res; 1999 Dec; 89(3):247-57. PubMed ID: 10708271
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potentiation of antidepressants with lithium or carbamazepine in treatment-resistant depression.
    Rybakowski JK; Suwalska A; Chlopocka-Woźniak M
    Neuropsychobiology; 1999 Sep; 40(3):134-9. PubMed ID: 10494048
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A report on three patients with "rapid cycling" unipolar depression.
    Tay LK; Dunner DL
    Compr Psychiatry; 1992; 33(4):253-5. PubMed ID: 1643866
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Carbamazepine extended-release capsules use in bipolar disorder: efficacy and safety in adult patients.
    Ginsberg LD
    Ann Clin Psychiatry; 2006; 18 Suppl 1():9-14. PubMed ID: 16754406
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Variability of brain lithium levels during maintenance treatment: a magnetic resonance spectroscopy study.
    Sachs GS; Renshaw PF; Lafer B; Stoll AL; Guimarães AR; Rosenbaum JF; Gonzalez RG
    Biol Psychiatry; 1995 Oct; 38(7):422-8. PubMed ID: 8672602
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hematological effects of lithium potentiation of carbamazepine in patients with affective illness.
    Joffe RT
    Int Clin Psychopharmacol; 1988 Jan; 3(1):53-7. PubMed ID: 3128600
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Decreasing lithium dosage reduces morbidity and side-effects during prophylaxis.
    Coppen A; Abou-Saleh M; Milln P; Bailey J; Wood K
    J Affect Disord; 1983 Nov; 5(4):353-62. PubMed ID: 6229567
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A prospective open-label trial of extended-release carbamazepine monotherapy in children with bipolar disorder.
    Joshi G; Wozniak J; Mick E; Doyle R; Hammerness P; Georgiopoulos A; Kotarski M; Aleardi M; Williams C; Walls S; Biederman J
    J Child Adolesc Psychopharmacol; 2010 Feb; 20(1):7-14. PubMed ID: 20166791
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A lithium and carbamazepine combination in the treatment of bipolar disorder--a preliminary report.
    Inoue K; Arima S; Tanaka K; Fukui Y; Kato N
    Folia Psychiatr Neurol Jpn; 1981; 35(4):465-75. PubMed ID: 6806160
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?
    Hollander E; Pallanti S; Allen A; Sood E; Baldini Rossi N
    Am J Psychiatry; 2005 Jan; 162(1):137-45. PubMed ID: 15625212
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Self-reported adherence to treatment with mood stabilizers, plasma levels, and psychiatric hospitalization.
    Scott J; Pope M
    Am J Psychiatry; 2002 Nov; 159(11):1927-9. PubMed ID: 12411230
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictors of interepisode symptoms and relapse in affective disorder patients treated with lithium carbonate.
    Goodnick PJ; Fieve RR; Schlegel A; Baxter N
    Am J Psychiatry; 1987 Mar; 144(3):367-9. PubMed ID: 3103474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.